Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
127.12
+1.85 (+1.48%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,589,845
Open
124.78
Bid (Size)
127.06 (200)
Ask (Size)
128.20 (100)
Prev. Close
125.27
Today's Range
124.70 - 127.61
52wk Range
88.57 - 128.70
Shares Outstanding
1,253,809,440
Dividend Yield
2.49%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gilead Sciences Inc (NASDAQ:GILD) Demonstrates Strong Dividend Reliability and Profitability
↗
November 25, 2025
Gilead Sciences (GILD) is a reliable dividend stock with a 2.53% yield, 10-year payment history, and a low payout ratio. Strong profitability and a debt-free balance sheet support its sustainable...
Via
Chartmill
Gilead Foundation Commits Over $3 Million to Address Food Insecurity
November 24, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Performance
YTD
+38.4%
+38.4%
1 Month
+5.5%
+5.5%
3 Month
+10.8%
+10.8%
6 Month
+16.5%
+16.5%
1 Year
+40.5%
+40.5%
More News
Read More
$1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth This Much Today
↗
November 20, 2025
Via
Benzinga
Gilead Sciences Inc Chart Analysis
↗
November 19, 2025
Via
Talk Markets
Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment
↗
November 19, 2025
Via
Benzinga
Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study
↗
November 19, 2025
Via
Stocktwits
Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown
↗
November 09, 2025
Via
Stocktwits
Wall Street Braces for Impact as Delayed Jobs Report Emerges from Data Blackout
November 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Uncover the latest developments among S&P500 stocks in today's session.
↗
November 18, 2025
Via
Chartmill
Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa
November 18, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences's Options: A Look at What the Big Money is Thinking
↗
November 17, 2025
Via
Benzinga
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
1 Healthcare Stock to Own for Decades and 2 We Avoid
November 13, 2025
Via
StockStory
Topics
Stocks
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
November 13, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV
↗
November 13, 2025
Via
Stocktwits
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
↗
November 13, 2025
Via
Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
↗
November 13, 2025
Via
Chartmill
2 Supercharged Dividend Stocks to Buy Now
↗
November 13, 2025
Via
The Motley Fool
Topics
ETFs
Intellectual Property
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
November 13, 2025
Via
Benzinga
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial
November 13, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Stocks
Is the AI Rally a Bubble? Impact on Commodity Demand and Defensive Stock Rotation
November 11, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
November 10, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
GBK Brand Bar and Meals on Me Host the Official Backstage Lounge at the 40th Annual Rock & Roll Hall of Fame Induction Ceremony Rehearsals
November 10, 2025
Via
24-7 Press Release
What's going on in today's session: S&P500 movers
↗
November 07, 2025
Via
Chartmill
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 127.12
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 11/25/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 159.38B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 159B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today